The Clinical Use of Lung MRI in Cystic Fibrosis: What, Now, How?

ABSTRACT: To assess airway and lung parenchymal damage noninvasively in cystic fibrosis (CF), chest MRI has been historically out of the scope of routine clinical imaging because of technical difficulties such as low proton density and respiratory and cardiac motion. However, technological breakthroughs have emerged that dramatically improve lung MRI quality (including signal-to-noise ratio, resolution, speed, and contrast). At the same time, novel treatments have changed the landscape of CF clinical care. In this contemporary context, there is now consensus that lung MRI can be used clinically to assess CF in a radiation-free manner and to enable quantification of lung disease severity. MRI can now achieve three-dimensional, high-resolution morphologic imaging, and beyond this morphologic informati

SUBMITTER: Dournes G 

PROVIDER: S-EPMC8579315 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature